Shana Van de Steene

Ms. Shana Van de Steene

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JLJing Liu
Jing Liu
CLChengnan Li
Chengnan Li
TBToon Brans
Toon Brans
AHAranit Harizaj
Aranit Harizaj
SSShana Van de Steene
Shana Van de Steene
Kevin BraeckmansKevin Braeckmans
Kevin Braeckmans
Nanoparticle mediated laser-induced photoporation is a physical cell membrane disruption approach to directly deliver extrinsic molecules into living cells, which is particularly promising in applications for both adherent and suspension cells. In this work, we explored surface modifications of graphene quantum dots (GQD) and reduced graphene oxide (rGO) with polyethylene glycol (PEG) and polyethyleneimine (PEI) to enhance colloidal stability while retaining photoporation functionality. After photoporation with FITC-dextran 10 kDa (FD10), the percentage of positive HeLa cells (81% for GQD-PEG, 74% for rGO-PEG and 90% for rGO-PEI) increased approximately two-fold compared to the bare nanomaterials. While for Jurkat suspension cells, the photoporation efficiency with polymer-modified graphene-based nanomaterial reached as high as 80%. Cell viability was >80% in all these cases. In addition, polymer functionalization proved to be beneficial for the delivery of larger macromolecules (FD70 and FD500) as well. Finally, we show that rGO is suitable for photoporation using a near-infrared laser to reach 80% FD10 positive HeLa cells at 80% cell viability. We conclude that modification of graphene-based nanoparticles with PEG and especially PEI provide better colloidal stability in cell medium, resulting in more uniform transfection and overall increased efficiency.

1 October 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
JRJeroen Van Renterghem
Jeroen Van Renterghem
SSShana Van de Steene
Shana Van de Steene
TDTryfon Digkas
Tryfon Digkas
MRMargarethe Richter
Margarethe Richter
CVChris Vervaet
Chris Vervaet
TBThomas De Beer
Thomas De Beer

1 September 2020 in Talanta
Verified
Journal Article
Closed access
YTYaxin Tie
Yaxin Tie
CDCéline Duchateau
Céline Duchateau
SSShana Van de Steene
Shana Van de Steene
CMCorenthin Mees
Corenthin Mees
KBKris De Braekeleer
Kris De Braekeleer
EDEric Deconinck
Eric Deconinck

26 April 2023 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SSShana Van de Steene
Shana Van de Steene
JRJ. Van Renterghem
J. Van Renterghem
Valérie VanhoorneValérie Vanhoorne
Valérie Vanhoorne
CVChris Vervaet
Chris Vervaet
Ashish KumarAshish Kumar
Ashish Kumar
TBT. De Beer
T. De Beer

16 September 2023 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SSShana Van de Steene
Shana Van de Steene
JRJ. Van Renterghem
J. Van Renterghem
Valérie VanhoorneValérie Vanhoorne
Valérie Vanhoorne
CVChris Vervaet
Chris Vervaet
AKA. Kumar
A. Kumar
TBT. De Beer
T. De Beer